Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum

Annals of Clinical Biochemistry

Volumn 35, Issue 6, 1998, Pages 745-753

  Ledue, Thomas B ^a   Weiner, Debra L ^b   Sipe, Jean D ^c   Poulin, Sue E ^a   Collins, Marilyn F ^a   Rifai, Nader ^b  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute phase proteins; Inflammation; Turbidimetry

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; HEMOGLOBIN; MANNOSE BINDING PROTEIN; SERUM AMYLOID A;

ACCURACY; ADULT; AGE; AGED; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CALIBRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFERENCE VALUE; REGRESSION ANALYSIS;

EID: 0031754706     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500607     Document Type: Article

References (39)

1. Kushner I. Acute phase response. Clin Aspects Autoimm 1989; 3: 20-30
2. Whicher JT. The role of the acute phase proteins. Diag Med 1981; June: 52-69
3. Kushner I. The phenomenon of the acute phase response. Ann NY Acad Sci 1982; 389: 39-48
4. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80
5. Baumann H, Richards C, Gauldie J. Interaction among hepatocyte stimulating factors, interleukin I, and glucorcorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. J Immunol 1987; 139: 4122-8
6. Thompson D, Harrison SP, Evans SW, Whicher JT. Insulin modulation of acute phase protein production in human hepatoma cell line. Cytokine 1991; 3: 619-26
7. Castell JV, Gomez-Lechon MJ, David M, Fahra R, Trullenque R, Heinrich PC. Acute phase response of human hepatocytes: regulation of acute phase protein synthesis by interleukin-6. Hepatology 1990; 12: 1179-86
8. Gewurz H. Biology of C-reactive protein and the acute phase response. Hosp Prac 1982; June: 67-81
9. Malle E, Steinmetz A, Raynes JG. Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis 1993; 102: 131-46
10. Super M, Thiel S, Lu J, Levinsky RJ, Turner MW. Association of low levels of mannan-binding protein with a common detect of opsonization. Lancet 1989; ii: 1236-8
11. Ezekowitz RAB, Day L, Herman G. A human mannose-binding protein is an acute phase reactant that shares sequence homology with other vertebrate lectins. J Exp Med 1988; 167: 1034-46
12. Kawasaki M, Kawasaki T, Yamashura I. Isolation and characterization of a mannose-binding protein from human serum. Biol Chem 1983; 94: 937-42
13. Ikeda K, Sannoh T, Kawasaki M, Kawasaki T, Yamashura I. Serum lectin with known structure activates complement through the classical pathway. J Biol Chem 1987; 262: 7451-6
14. Schweinle JE, Ezekowitz RAB, Tenner AJ, Kuhlmer M, Joines KA. Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose rich isolate of Salmonella. J Clin Invest 1989; 84: 1821-9
15. Summerfield JA, Sumiya M, Levin M, Turner MW. Association of mutations in mannose binding protein gene with childhood infections in consecutive hospital series. BMJ 1997; 314: 1229-32
16. Summerfield JA, Ryder S, Sumiya M, Thursz M, Gorchein A, Montiel MA, Turner MW. Mannose-binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995; 345: 886-9
17. Hokama Y, Nakamura R. C-reactive protein-Current status and future perspectives. J Clin Lab Anal 1987; 1: 15-27
18. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35
19. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assman G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost 1995; 73: 374-8
20. Ridker PM, Cushman M, Stampfer MJ, Tracy R, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9
21. Godenir NL, Jeenach MS, Coetzee GA, Van der Westhuzzen DR, Strachan AF, DeBeer F. Standardization of the quantitation of serum amyloid A protein (SAA) in human serum. J Immunol Meth 1985; 83: 217-25
22. Sable KG, Wadsworth CH. C-reactive protein in early diagnosis of neonatal septicemia. Scand J Clin Lab Invest 1979; 68: 825-31
23. Kapyaho K, Welin KG, Tanner P, Karkkainen T, Weber T. Rapid determination of C-reactive protein by enzyme immunoassay using two monoclonal antibodies. Scand J Clin Lab Invest 1989; 49: 389-93
24. Bienvenu J, Whicher JT, Aguzzi F. C-reactive protein. In: Ritchie RF, Navolotskaia O, eds. Serum Proteins in Clinical Medicine, Volume 1. Scarborough ME, USA: Foundation for Blood Research, 1996: 7.01.1-7.01.5
25. Terai I, Kunihiko K, Fujita T, Hagiwara K. Human serum mannose binding protein (MBP): Development of an enzyme-linked immunosorbent assay (ELISA) and determination of levels in serum from 1085 normal Japanese and in some body fluids. Biochem Med Metab Biol 1993; 50: 111-9
26. Whicher JT. Serum Amyloid A. In: Ritchie RF, Navolotskaia O, eds. Serum Proteins in Clinical Medicine, Volume 1. Scarborough ME, USA: Foundation for Blood Research, 1996: 7.02.1-7.02.5
27. Hart WR. C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med 1989; 56: 126-30
28. Maury CPJ. Comparative study of serum amyloid A and C-reactive protein in disease. Clin Sci 1985; 68: 233-8
29. Sipe JD. Acute phase proteins in osteoarthritis. Semin Arthritis Rheum 1995; 25: 75-86
30. Patel P, Mendall MA, Carrington DJ, Strachan D, Leatham E, Molineaux N, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4
31. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. BMJ 1996; 312: 1061-5
32. Morrow DA, Antman EM, Rifai NR, McCabe CH, Cannon CP, Braunwald E. C-reactive protein and rapid bedside troponin-T independently predict mortality in acute coronary syndromes: a TIMI 11A substudy. Circulation 1997; 96(suppl): 216
33. Whicher JT, Dieppe PA. Acute phase proteins. Clin Immunol Aller 1995; 5: 425-6
34. Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V. C-reactive protein in the serial assessment of disease activity in RA. Scand J Rheumatol 1984; 13: 39-44
35. Pereira Da Silva JA, Elkon KB, Hughes GR, Dyck RF, Pepys MB. C-reactive protein levels in systemic lupus erythematosus: a classification criterion? Arthritis Rheum 1980; 23: 770-1
36. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine 1995; 3: 237-43
37. Kilpatrick DC. Mannan binding protein in sera positive for rheumatoid factor. Br J Rheumatol 1997; 2: 207-9
38. Davies EJ, Teh LS, Ordi-Ros J, Snowden N, Hillarby MC, Hajeer A, et al. A dysfunctional allele of the mannose binding protein gene associates with systemic lupus erythematosus in a Spanish population. J Rheumatol 1997; 3: 485-8
39. Sullivan KE, Wooten C, Goldman D, Petri M. Mannose-binding protein genetic polymorphisms in black patients with systemic lupus erythematosus. Arthritis Rheum 1996; 12: 2046-51